IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -97.3% | 100 | -96.8% | 0.00% | -100.0% |
| Q1 2022 | $112,000 | -13.8% | 3,100 | -27.7% | 0.01% | +20.0% |
| Q4 2021 | $130,000 | +261.1% | 4,290 | -47.7% | 0.01% | +400.0% |
| Q3 2021 | $36,000 | +12.5% | 8,200 | +41.4% | 0.00% | 0.0% |
| Q2 2021 | $32,000 | – | 5,800 | +480.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $6,000 | -94.7% | 1,000 | -90.0% | 0.00% | -91.7% |
| Q1 2019 | $113,000 | +213.9% | 10,000 | -50.2% | 0.01% | +300.0% |
| Q4 2018 | $36,000 | -48.6% | 20,100 | +12.9% | 0.00% | -25.0% |
| Q3 2018 | $70,000 | +40.0% | 17,800 | -6.0% | 0.00% | 0.0% |
| Q2 2018 | $50,000 | -52.8% | 18,930 | -20.5% | 0.00% | -55.6% |
| Q1 2018 | $106,000 | -86.7% | 23,800 | -51.9% | 0.01% | -72.7% |
| Q4 2017 | $795,000 | -40.8% | 49,497 | -40.3% | 0.03% | -34.0% |
| Q3 2017 | $1,342,000 | +22.1% | 82,841 | -11.3% | 0.05% | +25.0% |
| Q2 2017 | $1,099,000 | +38.2% | 93,447 | +30.5% | 0.04% | +21.2% |
| Q1 2017 | $795,000 | -58.4% | 71,583 | -52.6% | 0.03% | -51.5% |
| Q4 2016 | $1,913,000 | +21.9% | 151,012 | -12.5% | 0.07% | -4.2% |
| Q3 2016 | $1,569,000 | +18.8% | 172,665 | +20.0% | 0.07% | +6.0% |
| Q2 2016 | $1,321,000 | -29.1% | 143,840 | +14.1% | 0.07% | -45.5% |
| Q1 2016 | $1,864,000 | -57.7% | 126,028 | -47.8% | 0.12% | -49.8% |
| Q4 2015 | $4,404,000 | – | 241,656 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |